STMN1

Stathmin · P16949 · STMN1 on Sugi Atlas →

0 patent compounds predicted against STMN1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to STMN1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma PHASE3COMPLETED
Biologic Correlative Taxotere/AC PHASE2COMPLETED
Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis PHASE1/PHASE2RECRUITING
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing PHASE1/PHASE2NOT_YET_RECRUITING
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation PHASE2UNKNOWN
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Study of ABT-751 in Patients With Refractory Hematologic Malignancies PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors PHASE1WITHDRAWN
In Vivo Lithium Treatment Effects on Gene Expression Levels in Lymphoblastoid Cell Lines From Human Healthy Subjects PHASE1COMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Biomarkers in the Diagnosis and Prognosis of NAFLD nanRECRUITING
New Genes in the Carcinogenesis of Colorectal Cancer nanUNKNOWN
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development nanCOMPLETED
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq) nanRECRUITING
Developing Genetic Education for Smoking Cessation nanCOMPLETED
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer nanNOT_YET_RECRUITING
Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay nanCOMPLETED
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a STMN1 binder may also engage these)

ProteinNameSimilarity
Q4R712 1.000 Q4R712 →
Q6DUB7 1.000 Q6DUB7 →
Q3T0C7 1.000 Q3T0C7 →
A9YWH3 1.000 A9YWH3 →
P13668 1.000 P13668 →
P54227 1.000 P54227 →
P31395 0.995 P31395 →
Q5R4C5 0.962 Q5R4C5 →
P63042 0.962 P63042 →
Q9H169 0.961 Q9H169 →
P63043 0.957 P63043 →
O70166 0.942 O70166 →
Q9JHU6 0.939 Q9JHU6 →
O93388 0.933 O93388 →
A4IFK9 0.931 A4IFK9 →
Q5RE12 0.930 Q5RE12 →
Q7Z422 0.927 Q7Z422 →
SUDS3 Sin3 histone deacetylase corepressor complex component SDS3 0.927 landscape →
Q8BR65 0.926 Q8BR65 →
Q6NXN1 0.926 Q6NXN1 →
Q5R8C6 0.926 Q5R8C6 →
Q9NZ72 0.926 Q9NZ72 →
Q4R4N5 0.926 Q4R4N5 →
Q5RBB8 0.925 Q5RBB8 →
Q5XIA2 0.924 Q5XIA2 →
Q2KI04 0.923 Q2KI04 →
A6H6W9 0.922 A6H6W9 →
P21818 0.920 P21818 →
STMN2 Stathmin-2 0.917 landscape →
Q9Y4J8 0.917 Q9Y4J8 →